Showing results (1461-1470 of 4,030) with videos related to

Sort By:
Pageof 403
American Journal of Nephrology|March 22, 2006
Proteomic profiling of urinary protein excretion in the factor H-deficient mouseMichael C Braun, Li Li, Baozhen Ke, et al.
American Journal of Nephrology|January 11, 1991
Production and kinetics of interleukin-1 in hemodialysis. In vivo and in vitro studyD Donati, D Degiannis, L Homer, et al.
American Journal of Nephrology|January 1, 1991
Acquired renal cystic disease mimicking adult polycystic kidney disease in a patient undergoing long-term hemodialysisM Kessler, P Testevuide, B Aymard, et al.
American Journal of Nephrology|February 21, 2008
Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysisGeorge Jerums, Sianna Panagiotopoulos, Erosha Premaratne, et al.
American Journal of Nephrology|February 21, 2008
Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measuresMohammad Rahnavardi, Seyed Mohammadmehdi Hosseini Moghaddam, Seyed Moayed Alavian
American Journal of Nephrology|March 28, 2008
Human leukocyte antigen DRB1 alleles predict risk and disease progression of immunoglobulin A nephropathy in Han ChineseHui-Xia Cao, Ming Li, Jing Nie, et al.
American Journal of Nephrology|March 14, 2008
Is fetuin-A/alpha2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?Jonas Axelsson, Xin Wang, Markus Ketteler, et al.
American Journal of Nephrology|January 1, 1991
Mesangiocapillary glomerulonephritis in Down's syndromeS K Gupta, V S Venkataseshan, J Churg
American Journal of Nephrology|March 21, 2008
Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patientsElísio Costa, Brian J G Pereira, Petronila Rocha-Pereira, et al.
Pageof 403